Slørdal L, Sager G, Huseby N E, Aarbakke J
Department of Pharmacology, University of Tromsø, Norway.
J Pharm Pharmacol. 1988 Jan;40(1):50-2. doi: 10.1111/j.2042-7158.1988.tb05149.x.
We have examined the in-vitro distribution of 7-hydroxymethotrexate (7-OH-MTX), a cytotoxic metabolite of methotrexate (MTX), in human blood, and its protein binding in serum. The distribution of 7-OH-MTX (10(-6) M) in fresh samples of whole blood was studied at 37 degrees C and pH 7.51 +/- 0.05 (mean +/- s.d.), and its protein binding was assessed by equilibrium dialysis of serum against Krebs Ringer phosphate buffer at 37 degrees C and pH 7.41 +/- 0.07 (mean +/- s.d.). 7-OH-MTX had a mean cell/plasma concentration ratio of 0.03 (range 0-0.27, n = 18). It was extensively bound in human serum, with a bound fraction of 90.4 +/- 3.3% (mean +/- s.d.) in healthy volunteers (n = 11), and significantly lower, 82.3 +/- 4.0% (mean +/- s.d.), in hypoalbuminaemic surgical patients (n = 7). The binding of 7-OH-MTX was correlated with serum albumin (HSA) concentrations (r = 0.72, P less than 0.0007, n = 18). Blood distribution data support the contention that 7-OH-MTX has a small volume of distribution, and HSA appears to be mainly responsible for the high degree of its protein binding in serum.
我们研究了甲氨蝶呤(MTX)的细胞毒性代谢产物7-羟基甲氨蝶呤(7-OH-MTX)在人血液中的体外分布及其在血清中的蛋白结合情况。在37℃和pH 7.51±0.05(均值±标准差)条件下,研究了7-OH-MTX(10⁻⁶ M)在新鲜全血样本中的分布,并通过在37℃和pH 7.41±0.07(均值±标准差)条件下,将血清与 Krebs Ringer 磷酸盐缓冲液进行平衡透析来评估其蛋白结合情况。7-OH-MTX的平均细胞/血浆浓度比为0.03(范围0 - 0.27,n = 18)。它在人血清中广泛结合,在健康志愿者(n = 11)中的结合分数为90.4±3.3%(均值±标准差),而在低白蛋白血症手术患者(n = 7)中显著降低,为82.3±4.0%(均值±标准差)。7-OH-MTX的结合与血清白蛋白(HSA)浓度相关(r = 0.72,P < 0.0007,n = 18)。血液分布数据支持了7-OH-MTX分布容积较小的观点,并且HSA似乎是其在血清中高度蛋白结合的主要原因。